Probiotics and Hospital Outcome in the Elderly - Full Text View

Sponsor:	Kaplan-Harzfeld Medical Center
Information provided by:	Kaplan-Harzfeld Medical Center
ClinicalTrials.gov Identifier:	NCT00794924

Purpose

Probiotics have been shown to reduce the rate of diarrhea and constipation. The purpose of this study was to investigate if probiotics could improve outcome of hospitalized orthopedic elderly patients.

Condition	Intervention
Diarrhea Constipation	Dietary Supplement: VSL#3 Dietary Supplement: placebo

Study Type:	Interventional
Study Design:	Prevention, Randomized, Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Placebo Control, Parallel Assignment, Efficacy Study
Official Title:	Effects of Commercially Available Probiotics on Hospital Outcome

Resource links provided by NLM:

MedlinePlus related topics: Constipation Diarrhea Dietary Supplements Diets

U.S. FDA Resources

Further study details as provided by Kaplan-Harzfeld Medical Center:

Primary Outcome Measures:

Reduction in Number of Days of Either Constipation or Diarrhea in Comparison to the Control Group [ Time Frame: 45 days of measuring the outcome ] [ Designated as safety issue: Yes ]

Secondary Outcome Measures:

Improvement in Nutritional and Immunological Measurements [ Time Frame: 45 days ] [ Designated as safety issue: Yes ]

Enrollment:	345
Study Start Date:	February 2004
Study Completion Date:	January 2005
Primary Completion Date:	January 2005 (Final data collection date for primary outcome measure)

Arms	Assigned Interventions
Probiotics, VSL#3: Experimental Acutely hospitalized elderly patients in a geriatric orthopedic rehabilitation department received commercially available probiotics (VSL#3) for 45 days.	Dietary Supplement: VSL#3 one sachet per day, for 45 consecutive days
Placebo: Placebo Comparator Acutely hospitalized elderly patients in a geriatric orthopedic rehabilitation department received placebo sachets for 45 days.	Dietary Supplement: VSL#3 one sachet per day, for 45 consecutive days Dietary Supplement: placebo one sachet per day, for 45 consecutive days

Detailed Description:

The patients were divided into two groups. One received probiotics for 45 days and the second received placebo. The patients had a clinical and epidemiological as well as nutritional assessment. They were followed-up as for their bowel movements, abdominal pain and nosocomial infections and for the incidence of helicobacter pylori and clostridiume difficille diarrhea.

Eligibility

Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Patients who were hospitalized in the Department of Geriatric Orthopedic Rehabilitation a week before their enrollment in the study and signed an informed consent.

Exclusion Criteria:

Known or suspected allergy to any probiotics
Neutropenia
Inability to sign an informed consent

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00794924

Sponsors and Collaborators

Kaplan-Harzfeld Medical Center

Investigators

Principal Investigator:

Hilla Zahroni, MA

Chief dietician

More Information

No publications provided

Responsible Party:	Chief dietician, Harzfeld Geriatric Medical Center ( Hilla Zharoni )
Study ID Numbers:	Probiotics and elderly
Study First Received:	October 28, 2008
Results First Received:	October 28, 2008
Last Updated:	November 19, 2008
ClinicalTrials.gov Identifier:	NCT00794924 History of Changes
Health Authority:	Israel: Ministry of Health

Keywords provided by Kaplan-Harzfeld Medical Center:

probiotics
elderly
motility
diarrhea

Additional relevant MeSH terms:

Signs and Symptoms
Diarrhea
Signs and Symptoms, Digestive
Constipation

ClinicalTrials.gov processed this record on February 09, 2010